tirzepatide cardiovascular outcomes trial results august 2025 Impact of Body Mass Index, Central Adiposity, and Weight Loss on the Benefits of in HFpEF: The SUMMIT Tirzepatide Demonstrates Cardioprotective Effects in

What Dose of Zepbound Is Most Effective: How 5, 10, and 15 mg Compare in the Trials In the trial that got Zepbound approved, the average person on the highest 15 mg dose lost 20.9% of their body weight over 72 weeks

For detailed guidance on injection technique, our guide on where to inject GLP-1 medications covers best practices for minimizing discomfort and reactions

Problems with your pancreas and gallbladder are rare but serious side effects of tirzepatide, so its worth getting checked just in case

A stall at 15 mg is a signal to reassess the overall approach, not to exceed the label

Compounded GLP-1s Are Not FDA-Approved Jorge Moreno, MD, an assistant professor and obesity medicine doctor at Yale Medicine in New Haven, Connecticut, says the findings highlight a broader concern that obesity specialists have about compounded versions of GLP-1 medications